NCLT Chandigarh allows Fortis to withdraw SRL demerger scheme

The National Company Law Tribunal bench in Chandigarh has allowed Fortis Healthcare to withdraw its scheme to demerge SRL diagnostics from the group and merge it with its step down subsidiary, the company told stock exchanges on Friday.

Fortis wanted to withdraw the composite scheme of arrangement and amalgamation between the group, Fortis Malar Hospitals and SRL due to reasons beyond the its control and its recently launched fresh bidding process for a deal.

The process was to take 6-8 months but has taken over 19 months and is still not complete, the company told BSE on Thursday.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Over-the-counter sale of cough syrup barred

    Over-the-counter sale of cough syrup barred

    FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address

    FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address

    Yashoda Medicity’s AI-enabled E- ICU poised to make Quality Critical Care Universal

    Yashoda Medicity’s AI-enabled E- ICU poised to make Quality Critical Care Universal

    Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

    Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

    No cough syrups without a doctor’s prescription – New rules announced

    No cough syrups without a doctor’s prescription – New rules announced

    CSIR-IIIM launches two-month certificate course On cGMP-compliant herbal drug manufacturing

    CSIR-IIIM launches two-month certificate course On cGMP-compliant herbal drug manufacturing